{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:43:41Z","timestamp":1790120621279,"version":"4.0.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Eastern equine encephalitis virus (EEEV; Family Togaviridae), is an endemic pathogen first isolated in 1933 with distribution primarily in the eastern US and Canada. The virus has caused periodic outbreaks in both humans and equines along the eastern seaboard and through the southern coastal states. While the outbreaks caused by EEEV have been sporadic and varied geographically since the discovery of the virus, it has continued to expand its range moving into the Midwest states as well. Additionally, one of the largest outbreaks was recorded in 2019 prompting concerns that outbreaks were becoming larger and more frequent. Because the virus can cause serious disease and because it is transmissible by both mosquitoes and aerosol, there has been renewed interest in identifying potential options for vaccines. Currently, there are no licensed vaccines and control relies completely on the use of personal protective measures and integrated vector control which have limited effectiveness for the EEEV vectors. Several vaccine candidates are currently being developed; this review will describe the multiple options under consideration for future development and assess their relative advantages and disadvantages.<\/jats:p>","DOI":"10.1093\/jme\/tjab135","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T11:06:00Z","timestamp":1636023960000},"page":"20-26","source":"Crossref","is-referenced-by-count":12,"title":["Resurgence of Interest in Eastern Equine Encephalitis Virus Vaccine Development"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2653-7642","authenticated-orcid":false,"given":"Ann M","family":"Powers","sequence":"first","affiliation":[{"name":"Division of Vector-Borne Diseases, Centers for Diseases Control and Prevention, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"2022011306521404000_CIT0001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4269\/ajtmh.1970.19.123","article-title":"An inactivated eastern equine encephalomyelitis vaccine propagated in chick-embryo cell culture. II. Clinical and serologic responses in man","volume":"19","author":"Bartelloni","year":"1970","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"2022011306521404000_CIT0002","first-page":"209","article-title":"Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells","volume":"74","author":"Berge","year":"1961","journal-title":"Amer. J. Hyg"},{"key":"2022011306521404000_CIT0003","doi-asserted-by":"crossref","first-page":"8521060","DOI":"10.1155\/2018\/8521060","article-title":"A multiagent alphavirus DNA vaccine delivered by intramuscular electroporation elicits robust and durable virus-specific immune responses in mice and rabbits and completely protects mice against lethal Venezuelan, western, and eastern equine encephalitis virus aerosol challenges","volume":"2018","author":"Dupuy","year":"2018","journal-title":"J. Immunol. Res"},{"key":"2022011306521404000_CIT0004","doi-asserted-by":"crossref","first-page":"e01274-17","DOI":"10.1128\/JVI.01274-17","article-title":"Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multi-valent, single-dose protection against lethal alphavirus challenge","volume":"92","author":"Erasmus","year":"2018","journal-title":"J Virol"},{"key":"2022011306521404000_CIT0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin. Infect. Dis"},{"key":"2022011306521404000_CIT0006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-1656(99)00131-5","article-title":"The use of bi-cistronic transfer vectors for the baculovirus expression system","volume":"75","author":"Finkelstein","year":"1999","journal-title":"J. Biotechnol"},{"key":"2022011306521404000_CIT0007","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM193809222191201","article-title":"Human encephalitis caused by the virus of the eastern variety of equine encephalomyelitis","volume":"219","author":"Fothergill","year":"1938","journal-title":"N Engl J Med"},{"key":"2022011306521404000_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.aje.a120789","article-title":"The 1959 outbreak of Eastern encephalitis in New Jersey. I. Introduction and description of outbreak","volume":"87","author":"Goldfield","year":"1968","journal-title":"Am. J. Epidemiol"},{"key":"2022011306521404000_CIT0009","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156652311795684731","article-title":"MVA and NYVAC as vaccines against emergent infectious diseases and cancer","volume":"11","author":"G\u00f3mez","year":"2011","journal-title":"Curr. Gene Ther"},{"key":"2022011306521404000_CIT0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization*","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu. Rev. Immunol"},{"key":"2022011306521404000_CIT0011","doi-asserted-by":"crossref","first-page":"e104708","DOI":"10.1371\/journal.pone.0104708","article-title":"Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge","volume":"9","author":"Honnold","year":"2014","journal-title":"Plos One"},{"key":"2022011306521404000_CIT0012","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1016\/j.vaccine.2018.06.064","article-title":"Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses","volume":"36","author":"Hu","year":"2018","journal-title":"Vaccine"},{"key":"2022011306521404000_CIT0013","first-page":"251","article-title":"Studies on the North American arthropod-borne encephalitides. III. Eastern equine encephalitis in wild birds","volume":"60","author":"Kissling","year":"1954","journal-title":"Am. J. Hyg"},{"key":"2022011306521404000_CIT0014","doi-asserted-by":"crossref","first-page":"eaav3113","DOI":"10.1126\/scitranslmed.aav3113","article-title":"A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates","volume":"11","author":"Ko","year":"2019","journal-title":"Sci Transl Med"},{"key":"2022011306521404000_CIT0015","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4269\/ajtmh.17-0927","article-title":"Eastern equine encephalitis virus in the United States, 2003-2016","volume":"98","author":"Lindsey","year":"2018","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"2022011306521404000_CIT0016","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.134.3478.565","article-title":"Eastern equine encephalomyelitis vaccine prepared in cell cultures","volume":"134","author":"Lowenthal","year":"1961","journal-title":"Science"},{"key":"2022011306521404000_CIT0017","doi-asserted-by":"crossref","first-page":"S978","DOI":"10.1093\/ofid\/ofz360.2450","article-title":"Safety and immunogenicity study of Eastern equine encephalitis vaccine","volume":"6","author":"Maryam","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022011306521404000_CIT0018","first-page":"1","article-title":"Eastern equine encephalomylitis,","volume-title":"The arboviruses: epidemiology and ecology","author":"Morris","year":"1988"},{"key":"2022011306521404000_CIT0019","doi-asserted-by":"crossref","first-page":"e01729-16","DOI":"10.1128\/JVI.01729-16","article-title":"Recombinant Isfahan virus and vesicular stomatitis virus vaccine vectors provide durable, multivalent, single-dose protection against lethal alphavirus challenge","volume":"91","author":"Nasar","year":"2017","journal-title":"J Virol"},{"key":"2022011306521404000_CIT0020","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant sindbis\/Venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"J. Virol"},{"key":"2022011306521404000_CIT0021","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.vaccine.2011.12.121","article-title":"A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation","volume":"30","author":"Pandya","year":"2012","journal-title":"Vaccine"},{"key":"2022011306521404000_CIT0022","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JVI.02297-13","article-title":"Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses","volume":"88","author":"Phillips","year":"2014","journal-title":"J. Virol"},{"key":"2022011306521404000_CIT0023","doi-asserted-by":"crossref","first-page":"e1002142","DOI":"10.1371\/journal.ppat.1002142","article-title":"Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism","volume":"7","author":"Plante","year":"2011","journal-title":"Plos Pathog"},{"key":"2022011306521404000_CIT0024","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","article-title":"The complexity and cost of vaccine manufacturing\u2014an overview","volume":"35","author":"Plotkin","year":"2017","journal-title":"Vaccine"},{"key":"2022011306521404000_CIT0025","doi-asserted-by":"crossref","first-page":"e00104-16","DOI":"10.1128\/CMR.00104-16","article-title":"Vaccine and therapeutic options to control chikungunya virus","volume":"31","author":"Powers","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"2022011306521404000_CIT0026","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1128\/JVI.01406-14","article-title":"Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses","volume":"88","author":"Reed","year":"2014","journal-title":"J. Virol"},{"key":"2022011306521404000_CIT0027","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2012.09.049","article-title":"Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis","volume":"30","author":"Reisler","year":"2012","journal-title":"Vaccine"},{"key":"2022011306521404000_CIT0028","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J. Virol"},{"key":"2022011306521404000_CIT0029","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.vaccine.2013.01.014","article-title":"A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus","volume":"31","author":"Roy","year":"2013","journal-title":"Vaccine"},{"key":"2022011306521404000_CIT0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00430-014-0384-8","article-title":"Electroporation for therapeutic DNA vaccination in patients","volume":"204","author":"S\u00e4llberg","year":"2015","journal-title":"Med. Microbiol. Immunol"},{"key":"2022011306521404000_CIT0031","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"Schmaljohn","year":"1982","journal-title":"Nature"},{"key":"2022011306521404000_CIT0032","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1128\/JVI.00449-13","article-title":"Functional characterization of the alphavirus TF protein","volume":"87","author":"Snyder","year":"2013","journal-title":"J. Virol"},{"key":"2022011306521404000_CIT0033","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Curr. Drug Targets. Infect. Disord"},{"key":"2022011306521404000_CIT0034","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.88.2291.505","article-title":"the occurrence in nature of \u201cEquine Encephalomyelitis\u201d in the ring-necked pheasant","volume":"88","author":"Tyzzer","year":"1938","journal-title":"Science"},{"key":"2022011306521404000_CIT0035","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.vaccine.2013.03.016","article-title":"Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies","volume":"31","author":"Volz","year":"2013","journal-title":"Vaccine"},{"key":"2022011306521404000_CIT0036","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1016\/j.vaccine.2007.07.061","article-title":"Chimeric Sindbis\/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"key":"2022011306521404000_CIT0037","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4269\/ajtmh.14-0055","article-title":"Current strategic thinking for the development of a trivalent alphavirus vaccine for human use","volume":"91","author":"Wolfe","year":"2014","journal-title":"Am. J. Trop. Med. Hyg"}],"container-title":["Journal of Medical Entomology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jme\/article-pdf\/59\/1\/20\/41961386\/tjab135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jme\/article-pdf\/59\/1\/20\/41961386\/tjab135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T06:53:20Z","timestamp":1642056800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jme\/article\/59\/1\/20\/6420334"}},"subtitle":[],"editor":[{"given":"Theodore","family":"Andreadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,11,4]]},"published-print":{"date-parts":[[2022,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jme\/tjab135","relation":{},"ISSN":["0022-2585","1938-2928"],"issn-type":[{"value":"0022-2585","type":"print"},{"value":"1938-2928","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,11,4]]}}}